Unseasonably high flu test rates in the UK, US West Coast and Japan, combined with a rising H1N1 strain carrying the G155E mutation, are leading experts to consider an earlier vaccine rollout.
Unseasonably high flu test rates in the UK, US West Coast and Japan, combined with a rising H1N1 strain carrying the G155E mutation, are leading experts to consider an earlier vaccine rollout.